Home/Filings/4/0001615219-22-000085
4//SEC Filing

Rosenblum Mark J 4

Accession 0001615219-22-000085

CIK 0001615219other

Filed

May 30, 8:00 PM ET

Accepted

May 31, 5:13 PM ET

Size

4.5 KB

Accession

0001615219-22-000085

Insider Transaction Report

Form 4
Period: 2022-05-31
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Purchase

    Common Stock

    2022-05-31$0.18/sh+28,000$5,040148,319 total

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001329154

Filing Metadata

Form type
4
Filed
May 30, 8:00 PM ET
Accepted
May 31, 5:13 PM ET
Size
4.5 KB